John B. Sorensen

RANDOMIZED TRIAL OF TACROLIMUS (PROGRAF) IN COMBINATION WITH AZATHIOPRINE OR MYCHOPHENOLATE MOFETIL VERSUS CYCLOSPORINE (NEORAL) WITH MYCOPHENOLATE MOFETIL AFTER CADAVERIC KIDNEY TRANSPLANTATION1, 2

Christopher P. Johnson, Nasimul Ahsan, Thomas A. Gonwa et al. · Transplantation · 2000 · 296 citations

Pharmacy, Nephrology, Pharmacotherapy +17

Randomized trial of tacrolimus + mycophenolate mofetil or azathioprine versus cyclosporine + mycophenolate mofetil after cadaveric kidney transplantation: results at three years

Thomas A. Gonwa, Christopher P. Johnson, Nasimul Ahsan et al. · Transplantation · 2003 · 143 citations

Medicine, Nephrology, Pharmacotherapy +15

RANDOMIZED TRIAL OF TACROLIMUS PLUS MYCOPHENOLATE MOFETIL OR AZATHIOPRINE VERSUS CYCLOSPORINE ORAL SOLUTION (MODIFIED) PLUS MYCOPHENOLATE MOFETIL AFTER CADAVERIC KIDNEY TRANSPLANTATION: RESULTS AT 2 YEARS1

Nasimul Ahsan, Christopher P. Johnson, Thomas A. Gonwa et al. · Transplantation · 2001 · 140 citations

Medicine, Nephrology, Pharmacotherapy +17

Liver transplantation in septuagenarians receiving model for end-stage liver disease exception points for hepatocellular carcinoma: The national experience#*

Jason J. Schwartz, Lisa M. Pappas, Heather F. Thiesset et al. · Liver Transplantation · 2012 · 63 citations

Medicine, Oncology, Surgery +16

Transplantation of ABO Group A2 Kidneys from Living Donors into Group O and B Recipients

John B. Sorensen, Wendy J. Grant, Legrand Belnap et al. · American Journal of Transplantation · 2001 · 62 citations

Medicine, Nephrology, Surgery +12